Glatiramer acetate immunization induces specific antibody and cytokine responses in ALS patients (Q58125524)

1

0 references

Paul H. Gordon

2

0 references

Christopher M. Hasiak

3

0 references

Francis J. Van Wetering

4

0 references

Howard E. Gendelman

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

6

0 references

publication date

January 2007

0 references

published in

0 references

volume

8

0 references

issue

4

0 references

page(s)

235-242

0 references

cites work

ALS: a disease of motor neurons and their nonneuronal neighbors

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Inflammatory processes in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Pharmacologic approaches to the treatment of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Vaccination with autoantigen protects against aggregated beta-amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Antibodies to glatiramer acetate do not interfere with its biological functions and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Immunomodulation by the copolymer glatiramer acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Accessibility control and machinery of immunoglobulin class switch recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Glatiramer acetate (Copaxone®) therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Treatment with glatiramer acetate induces specific IgG4 antibodies in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Seroconversion of anti-GM1 antibodies in patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Antimyelin antibodies in neurologic diseases. Immunofluorescent demonstration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Cross-reactions and specificities of monoclonal antibodies against myelin basic protein and against the synthetic copolymer 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Immunoglobulins from amyotrophic lateral sclerosis patients enhance spontaneous transmitter release from motor-nerve terminals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Neuroprotective agents for clinical trials in ALS: a systematic assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601

Treatment of multiple sclerosis with copolymer-1 (Copaxone): implicating mechanisms of Th1 to Th2/Th3 immune-deviation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701374601